Regarding the expression profile of these genes in other diseases (Fig. S7a; GSE26927), notable findings include: HD (reduced levels of PINK1 and ULK1) and MS (slight but significantly reduced levels of ATG3). This evidence concerns the gene ATG3 and myeloid sarcoma.